➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Express Scripts
McKesson
Harvard Business School
McKinsey

Last Updated: March 7, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for IW-1701

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for IW-1701?

IW-1701 is an investigational drug.

There have been 6 clinical trials for IW-1701. The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2017.

The most common disease conditions in clinical trials are Anemia, Sickle Cell, Esophageal Achalasia, and [disabled in preview]. The leading clinical trial sponsors are Ironwood Pharmaceuticals, Inc. and [disabled in preview].

There are four US patents protecting this investigational drug and forty international patents.

Recent Clinical Trials for IW-1701
TitleSponsorPhase
A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy VolunteersIronwood Pharmaceuticals, Inc.Phase 1
A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Olinciguat in Healthy Male VolunteersIronwood Pharmaceuticals, Inc.Phase 1
A Study of the Effect of IW-1701, a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)Ironwood Pharmaceuticals, Inc.Phase 2

See all IW-1701 clinical trials

Clinical Trial Summary for IW-1701

Top disease conditions for IW-1701
Top clinical trial sponsors for IW-1701

See all IW-1701 clinical trials

US Patents for IW-1701

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
IW-1701   Start Trial sGC stimulators Ironwood Pharmaceuticals, Inc. (Cambridge, MA)   Start Trial
IW-1701   Start Trial sGC stimulators Cyclerion Therapeutics, Inc. (Cambridge, MA)   Start Trial
IW-1701   Start Trial sGC stimulators IRONWOOD PHARMACEUTICALS, INC. (Cambridge, MA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Express Scripts
McKesson
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.